{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:10:11Z","timestamp":1787238611124,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100018936","name":"Universit\u00e4tsklinikum Heidelberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018936","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The APROVE-trial investigated the tolerability of postoperative proton beam therapy in women with cervical or endometrial cancer. The present analysis evaluated the secondary endpoints of health-related quality of life (HRQOL) and patient-reported symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>25 patients were included in this prospective phase-II-trial and treated with postoperative radiotherapy using protons alone or in combination with chemotherapy. To attain general and gynecologic-specific HRQOL measures, the EORTC-QLQ-C30 questionnaires combined with -QLQ-CX24 for cervical and -QLQ-EN24 for endometrial cancer were assessed at baseline, at the end of RT and up to 2\u00a0years after radiotherapy. The results were compared to an age-matched norm reference population. Symptoms were assessed using Common Terminology Criteria for Adverse Events (CTCAE) and institutional patient-reported symptoms grading.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Scores regarding global health status were markedly impaired at baseline (mean: 58.0\u2009\u00b1\u200920.1) compared to reference population data, but significantly (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.036) improved and evened out to comparable norm values 2\u00a0years after proton therapy (mean: 69.9\u2009\u00b1\u200919.3). Treatment caused acute and long-term worsening of pain (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048) and gastrointestinal symptoms (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016) for women with endometrial cancer, but no higher-grade CTCAE\u2009\u2265\u20093\u00b0 toxicity was observed. Dosimetric evaluation of rectum, sigmoid, large and small bowel showed no correlation with the reported gastrointestinal symptoms. After 2\u00a0years, fatigue had significantly improved (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.030), whereas patients with cervical cancer experienced more often lymphedema (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017). Scores for endometrial cancer pertaining to sexual activity (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.048) and body image (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.022) had improved post treatment; in the latter this effect persisted after 2\u00a0years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Proton beam therapy in the adjuvant setting was well tolerated with only low-grade side effects concerning gastrointestinal symptoms, lymphedema and pain. Overall quality of life was impaired at baseline, but patients were able to recover to values comparable to norm population 2\u00a0years after proton therapy. Larger studies are needed to confirm whether the benefit of proton therapy translates into a clinical effect. Sexual dysfunction remains an important issue.<\/jats:p>\n                    <jats:p>\n                      <jats:italic>Trial registration<\/jats:italic>\n                      : The trial was registered at\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\">https:\/\/clinicaltrials.gov<\/jats:ext-link>\n                      (ClinicalTrials.gov Identifier: NCT03184350, 09th June 2017).\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13014-023-02198-4","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:05:57Z","timestamp":1673222757000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Health-related quality of life and patient-reported symptoms after postoperative proton beam radiotherapy of cervical and endometrial cancer: 2-year results of the prospective phase II APROVE-trial"],"prefix":"10.1186","volume":"18","clinical-trial-number":[{"clinical-trial-number":"nct03184350","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Eva","family":"Meixner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Wark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Weykamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Lindel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Tobias","family":"Oelmann-Avendano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Krisam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schneeweiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Ellerbrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane","family":"H\u00f6rner-Rieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Herfarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Arians","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"issue":"3","key":"2198_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349. https:\/\/doi.org\/10.3322\/caac.21660. (PMID: 33538338).","journal-title":"CA Cancer J Clin"},{"key":"2198_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ejca.2019.12.013","volume":"127","author":"EEL Jansen","year":"2020","unstructured":"Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vok\u00f3 Z, Ivanu\u0161 U, McKee M, de Koning HJ, de Kok IMCM, EU-TOPIA consortium. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer. 2020;127:207\u201323. https:\/\/doi.org\/10.1016\/j.ejca.2019.12.013. (PMID: 31980322).","journal-title":"Eur J Cancer"},{"issue":"12","key":"2198_CR3","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1136\/ijgc-2019-001131","volume":"30","author":"MJE van den Akker","year":"2020","unstructured":"van den Akker MJE, Horeweg N, Beltman JJ, Creutzberg CL, Nout RA. Efficacy and toxicity of postoperative external beam radiotherapy or chemoradiation for early-stage cervical cancer. Int J Gynecol Cancer. 2020;30(12):1878\u201386. https:\/\/doi.org\/10.1136\/ijgc-2019-001131. (PMID: 32591371).","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"2198_CR4","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ygyno.2014.04.045","volume":"134","author":"R D\u00e1vila Fajardo","year":"2014","unstructured":"D\u00e1vila Fajardo R, van Os R, Buist MR, Uitterhoeve L, Westermann AM, Kenter GG, Rasch CR, Stalpers LJ. Post-operative radiotherapy in patients with early stage cervical cancer. Gynecol Oncol. 2014;134(1):52\u20139. https:\/\/doi.org\/10.1016\/j.ygyno.2014.04.045. (PMID: 24784874).","journal-title":"Gynecol Oncol"},{"issue":"4","key":"2198_CR5","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.ijrobp.2020.10.030","volume":"109","author":"CCB Post","year":"2021","unstructured":"Post CCB, de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger NPB, Ledermann JA, Khaw P, D\u2019Amico R, Fyles A, Baron MH, Kitchener HC, Nijman HW, Lutgens LCHW, Brooks S, J\u00fcrgenliemk-Schulz IM, Feeney A, Goss G, Fossati R, Ghatage P, Leary A, Do V, Lissoni AA, McCormack M, Nout RA, Verhoeven-Adema KW, Smit VTHBM, Putter H, Creutzberg CL. Long-term toxicity and health-related quality of life after adjuvant chemoradiation therapy or radiation therapy alone for high-risk endometrial cancer in the randomized PORTEC-3 trial. Int J Radiat Oncol Biol Phys. 2021;109(4):975\u201386. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.10.030. (PMID: 33129910).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2198_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00192-021-04798-8","volume":"33","author":"T de Morais Siqueira","year":"2022","unstructured":"de Morais Siqueira T, Derchain S, Juliato CRT, Pinto E Silva MP, Machado HC, Brito LGO. Vaginal stenosis in women with cervical or endometrial cancer after pelvic radiotherapy: a cross-sectional study of vaginal measurements, risk for sexual dysfunction and quality of life. Int Urogynecol J. 2022;33(3):637\u201349. https:\/\/doi.org\/10.1007\/s00192-021-04798-8. (PMID: 33891152).","journal-title":"Int Urogynecol J"},{"issue":"1","key":"2198_CR7","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1525-1438.2006.00348.x","volume":"16","author":"AH Brand","year":"2006","unstructured":"Brand AH, Bull CA, Cakir B. Vaginal stenosis in patients treated with radiotherapy for carcinoma of the cervix. Int J Gynecol Cancer. 2006;16(1):288\u201393. https:\/\/doi.org\/10.1111\/j.1525-1438.2006.00348.x. (PMID: 16445647).","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"2198_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13014-018-1126-7","volume":"13","author":"Y Lin","year":"2018","unstructured":"Lin Y, Chen K, Lu Z, Zhao L, Tao Y, Ouyang Y, Cao X. Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis. Radiat Oncol. 2018;13(1):177. https:\/\/doi.org\/10.1186\/s13014-018-1126-7. (PMID: 30217165\u202f;PMCID: PMC6137729).","journal-title":"Radiat Oncol"},{"issue":"2","key":"2198_CR9","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.ijrobp.2021.09.042","volume":"112","author":"BG Wortman","year":"2022","unstructured":"Wortman BG, Post CCB, Powell ME, Khaw P, Fyles A, D\u2019Amico R, Haie-Meder C, J\u00fcrgenliemk-Schulz IM, McCormack M, Do V, Katsaros D, Bessette P, Baron MH, Nout RA, Whitmarsh K, Mileshkin L, Lutgens LCHW, Kitchener HC, Brooks S, Nijman HW, Astreinidou E, Putter H, Creutzberg CL, de Boer SM. Radiation therapy techniques and treatment-related toxicity in the PORTEC-3 trial: comparison of 3-dimensional conformal radiation therapy versus intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2022;112(2):390\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.09.042. (PMID: 34610387).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"2198_CR10","doi-asserted-by":"publisher","first-page":"946","DOI":"10.3390\/cancers11070946","volume":"11","author":"ET Vitti","year":"2019","unstructured":"Vitti ET, Parsons JL. The radiobiological effects of proton beam therapy: impact on DNA damage and repair. Cancers (Basel). 2019;11(7):946. https:\/\/doi.org\/10.3390\/cancers11070946. (PMID: 31284432).","journal-title":"Cancers (Basel)"},{"issue":"1","key":"2198_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijrobp.2006.08.027","volume":"67","author":"D Schulz-Ertner","year":"2007","unstructured":"Schulz-Ertner D, Nikoghosyan A, Hof H, Didinger B, Combs SE, J\u00e4kel O, Karger CP, Edler L, Debus J. Carbon ion radiotherapy of skull base chondrosarcomas. Int J Radiat Oncol Biol Phys. 2007;67(1):171\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.08.027. (PMID: 17056193).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"2198_CR12","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1002\/cncr.31298","volume":"124","author":"M Mattke","year":"2018","unstructured":"Mattke M, Vogt K, Bougatf N, Welzel T, Oelmann-Avendano J, Hauswald H, Jensen A, Ellerbrock M, J\u00e4kel O, Haberer T, Herfarth K, Debus J, Uhl M. High control rates of proton- and carbon-ion-beam treatment with intensity-modulated active raster scanning in 101 patients with skull base chondrosarcoma at the Heidelberg Ion Beam Therapy Center. Cancer. 2018;124(9):2036\u201344. https:\/\/doi.org\/10.1002\/cncr.31298. (PMID: 29469932).","journal-title":"Cancer"},{"issue":"10","key":"2198_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13014-015-0402-z","volume":"17","author":"S Marnitz","year":"2015","unstructured":"Marnitz S, Wlodarczyk W, Neumann O, Koehler C, Weihrauch M, Budach V, Cozzi L. Which technique for radiation is most beneficial for patients with locally advanced cervical cancer? Intensity modulated proton therapy versus intensity modulated photon treatment, helical tomotherapy and volumetric arc therapy for primary radiation\u2014an intraindividual comparison. Radiat Oncol. 2015;17(10):91. https:\/\/doi.org\/10.1186\/s13014-015-0402-z. (PMID: 25896675; PMCID: PMC4404108).","journal-title":"Radiat Oncol"},{"issue":"3","key":"2198_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14338\/IJPT-17-00027.1","volume":"4","author":"MJ Xu","year":"2018","unstructured":"Xu MJ, Maity A, Vogel J, Kirk M, Zhai H, Both S, Lin LL. Proton therapy reduces normal tissue dose in extended-field pelvic radiation for endometrial cancer. Int J Part Ther. 2018;4(3):1\u201311. https:\/\/doi.org\/10.14338\/IJPT-17-00027.1. (PMID: 31773009; PMCID: PMC6871568).","journal-title":"Int J Part Ther"},{"issue":"1","key":"2198_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijrobp.2015.07.2205","volume":"95","author":"LL Lin","year":"2016","unstructured":"Lin LL, Kirk M, Scholey J, Taku N, Kiely JB, White B, Both S. Initial report of pencil beam scanning proton therapy for posthysterectomy patients with gynecologic cancer. Int J Radiat Oncol Biol Phys. 2016;95(1):181\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.07.2205. (PMID: 26372435).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2198_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13014-017-0926-5.PMID:29179751;PMCID:PMC5704365","volume":"12","author":"N Arians","year":"2017","unstructured":"Arians N, Lindel K, Krisam J, Herfarth K, Krug D, Akbaba S, Oelmann-Avendano J, Debus J. Prospective phase-II-study evaluating postoperative radiotherapy of cervical and endometrial cancer patients using protons\u2014the APROVE-trial. Radiat Oncol. 2017;12(1):188. https:\/\/doi.org\/10.1186\/s13014-017-0926-5.PMID:29179751;PMCID:PMC5704365.","journal-title":"Radiat Oncol"},{"issue":"Suppl. 2","key":"2198_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ijgo.12612","volume":"143","author":"F Amant","year":"2018","unstructured":"Amant F, Mirza MR, Koskas M, Creutzberg CL. Cancer of the corpus uteri. Int J Gynaecol Obstet. 2018;143(Suppl. 2):37\u201350.","journal-title":"Int J Gynaecol Obstet"},{"issue":"Suppl 2","key":"2198_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ijgo.12611","volume":"143","author":"N Bhatla","year":"2018","unstructured":"Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet. 2018;143(Suppl 2):22\u201336. https:\/\/doi.org\/10.1002\/ijgo.12611. (PMID: 30306584).","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"2198_CR19","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ijrobp.2007.09.042.PMID:18037584;PMCID:PMC2752724","volume":"71","author":"W Small Jr","year":"2008","unstructured":"Small W Jr, Mell LK, Anderson P, Creutzberg C, De Los SJ, Gaffney D, Jhingran A, Portelance L, Schefter T, Iyer R, Varia M, Winter K, Mundt AJ. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer. Int J Radiat Oncol Biol Phys. 2008;71(2):428\u201334. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.09.042.PMID:18037584;PMCID:PMC2752724.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2198_CR20","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, Ten Haken RK, Yorke ED. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys. 2010;76:S3-9. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.09.040. (PMID: 20171515; PMCID: PMC3431964).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2198_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-y","volume":"21","author":"B Emami","year":"1991","unstructured":"Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, Shank B, Solin LJ, Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109\u201322. https:\/\/doi.org\/10.1016\/0360-3016(91)90171-y. (PMID: 2032882).","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2198_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","volume":"85","author":"NK Aaronson","year":"1993","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JCJM, Kaasa S, Klee MC, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw KCA, Sullivan M, Takeda F. The European Organisation for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365\u201376.","journal-title":"J Natl Cancer Inst"},{"key":"2198_CR23","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1002\/cncr.22217","volume":"14","author":"ER Greimel","year":"2006","unstructured":"Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, et al. The European Organization for Research and Treatment of Cancer (EORTC) quality-of-life questionnaire cervical cancer module: EORTC QLQ-CX24. Cancer. 2006;14:1812\u201322.","journal-title":"Cancer"},{"key":"2198_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.08.014","author":"E Greimel","year":"2010","unstructured":"Greimel E, Nordin A, Lanceley A, et al. Psychometric validation of the European organisation for research and treatment of cancer quality of life questionnaire-endometrial cancer module (EORTC QLQ-EN24). Eur J Cancer. 2010. https:\/\/doi.org\/10.1016\/j.ejca.2010.08.014.","journal-title":"Eur J Cancer"},{"key":"2198_CR25","volume-title":"EORTC QLQ-C30 scoring manual","author":"P Fayers","year":"2001","unstructured":"Fayers P, Aaronson N, Bjordal K, et al. EORTC QLQ-C30 scoring manual. rd. Brussels: EORTC Publications; 2001.","edition":"rd"},{"issue":"1","key":"2198_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1200\/JCO.1998.16.1.139","volume":"16","author":"D Osoba","year":"1998","unstructured":"Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139\u201344. https:\/\/doi.org\/10.1200\/JCO.1998.16.1.139. (PMID: 9440735).","journal-title":"J Clin Oncol"},{"issue":"6","key":"2198_CR27","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/BF00439229","volume":"5","author":"MT King","year":"1996","unstructured":"King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996;5(6):555\u201367. https:\/\/doi.org\/10.1007\/BF00439229. (PMID: 8993101).","journal-title":"Qual Life Res"},{"issue":"1","key":"2198_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1200\/JCO.2010.28.0107","volume":"29","author":"K Cocks","year":"2011","unstructured":"Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. J Clin Oncol. 2011;29(1):89\u201396. https:\/\/doi.org\/10.1200\/JCO.2010.28.0107. (PMID: 21098316).","journal-title":"J Clin Oncol"},{"key":"2198_CR29","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejca.2020.06.002","volume":"137","author":"S Nolte","year":"2020","unstructured":"Nolte S, Waldmann A, Liegl G, Petersen MA, Groenvold M, Rose M, EORTC Quality of Life Group. Updated EORTC QLQ-C30 general population norm data for Germany. Eur J Cancer. 2020;137:161\u201370. https:\/\/doi.org\/10.1016\/j.ejca.2020.06.002. (PMID: 32777715).","journal-title":"Eur J Cancer"},{"issue":"12","key":"2198_CR30","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1002\/cncr.23094","volume":"110","author":"SY Park","year":"2007","unstructured":"Park SY, Bae DS, Nam JH, Park CT, Cho CH, Lee JM, Lee MK, Kim SH, Park SM, Yun YH. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer. 2007;110(12):2716\u201325. https:\/\/doi.org\/10.1002\/cncr.23094. (PMID: 17960806).","journal-title":"Cancer"},{"issue":"8","key":"2198_CR31","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/S1470-2045(16)30120-6","volume":"17","author":"SM de Boer","year":"2016","unstructured":"de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron MH, Kitchener HC, Nijman HW, Kruitwagen RF, Nout RA, Verhoeven-Adema KW, Smit VT, Putter H, Creutzberg CL, PORTEC study group. Toxicity and quality of life after adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): an open-label, multicentre, randomised, phase 3 trial. Lancet Oncol. 2016;17(8):1114\u201326. https:\/\/doi.org\/10.1016\/S1470-2045(16)30120-6. (PMID: 27397040).","journal-title":"Lancet Oncol"},{"issue":"5","key":"2198_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.ijrobp.2015.12.363","volume":"94","author":"K Kirchheiner","year":"2016","unstructured":"Kirchheiner K, P\u00f6tter R, Tanderup K, Lindegaard JC, Haie-Meder C, Petri\u010d P, Mahantshetty U, J\u00fcrgenliemk-Schulz IM, Rai B, Cooper R, D\u00f6rr W, Nout RA, EMBRACE Collaborative Group. Health-related quality of life in locally advanced cervical cancer patients after definitive chemoradiation therapy including image guided adaptive brachytherapy: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys. 2016;94(5):1088\u201398. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.12.363. (PMID: 26876955).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2198_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ygyno.2014.10.031","volume":"136","author":"K Kirchheiner","year":"2015","unstructured":"Kirchheiner K, Nout RA, Czajka-Pepl A, Ponocny-Seliger E, Sturdza AE, Dimipoulos JC, D\u00f6rr W, P\u00f6tter R. Health related quality of life and patient reported symptoms before and during definitive radio(chemo)therapy using image-guided adaptive brachytherapy for locally advanced cervical cancer and early recovery\u2014a mono-institutional prospective study. Gynecol Oncol. 2015;136(3):415\u201323. https:\/\/doi.org\/10.1016\/j.ygyno.2014.10.031. (PMID: 25462202).","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2198_CR34","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1006\/gyno.2002.6586","volume":"85","author":"E Greimel","year":"2002","unstructured":"Greimel E, Thiel I, Peintinger F, Cegnar I, Pongratz E. Prospective assessment of quality of life of female cancer patients. Gynecol Oncol. 2002;85(1):140\u20137. https:\/\/doi.org\/10.1006\/gyno.2002.6586. (PMID: 11925134).","journal-title":"Gynecol Oncol"},{"issue":"21","key":"2198_CR35","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.1200\/JCO.2008.20.2424","volume":"27","author":"RA Nout","year":"2009","unstructured":"Nout RA, Putter H, J\u00fcrgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Stenfert Kroese MC, van Bunningen BN, Smit VT, Nijman HW, van den Tol PP, Creutzberg CL. Quality of life after pelvic radiotherapy or vaginal brachytherapy for endometrial cancer: first results of the randomized PORTEC-2 trial. J Clin Oncol. 2009;27(21):3547\u201356. https:\/\/doi.org\/10.1200\/JCO.2008.20.2424. (PMID: 19546404).","journal-title":"J Clin Oncol"},{"issue":"2","key":"2198_CR36","doi-asserted-by":"publisher","first-page":"e89851","DOI":"10.1371\/journal.pone.0089851","volume":"9","author":"S Kumar","year":"2014","unstructured":"Kumar S, Rana ML, Verma K, Singh N, Sharma AK, Maria AK, Dhaliwal GS, Khaira HK, Saini S. PrediQt-Cx: post treatment health related quality of life prediction model for cervical cancer patients. PLoS ONE. 2014;9(2):e89851. https:\/\/doi.org\/10.1371\/journal.pone.0089851. (PMID: 24587074; PMCID: PMC3935936).","journal-title":"PLoS ONE"},{"issue":"33","key":"2198_CR37","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1200\/JCO.20.02530","volume":"39","author":"S Chopra","year":"2021","unstructured":"Chopra S, Gupta S, Kannan S, Dora T, Engineer R, Mangaj A, Maheshwari A, Shylasree TS, Ghosh J, Paul SN, Phurailatpam R, Charnalia M, Alone M, Swamidas J, Mahantshetty U, Deodhar K, Kerkar R, Shrivastava SK. Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial. J Clin Oncol. 2021;39(33):3682\u201392. https:\/\/doi.org\/10.1200\/JCO.20.02530. (Epub 2021 Sep 10 PMID: 34506246).","journal-title":"J Clin Oncol"},{"key":"2198_CR38","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.radonc.2021.08.019","volume":"163","author":"T Forster","year":"2021","unstructured":"Forster T, Hommertgen A, H\u00e4fner MF, Arians N, K\u00f6nig L, Harrabi SB, Schlampp I, K\u00f6hler C, Meixner E, Heinrich V, Weidner N, H\u00fcsing J, Sohn C, Heil J, Golatta M, Hof H, Krug D, Debus J, H\u00f6rner-Rieber J. Quality of life after simultaneously integrated boost with intensity-modulated versus conventional radiotherapy with sequential boost for adjuvant treatment of breast cancer: 2-year results of the multicenter randomized IMRT-MC2 trial. Radiother Oncol. 2021;163:165\u201376. https:\/\/doi.org\/10.1016\/j.radonc.2021.08.019. (PMID: 34480960).","journal-title":"Radiother Oncol"},{"issue":"3","key":"2198_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.radonc.2016.06.016","volume":"120","author":"MA van de Sande","year":"2016","unstructured":"van de Sande MA, Creutzberg CL, van de Water S, Sharfo AW, Hoogeman MS. Which cervical and endometrial cancer patients will benefit most from intensity-modulated proton therapy? Radiother Oncol. 2016;120(3):397\u2013403. https:\/\/doi.org\/10.1016\/j.radonc.2016.06.016. (PMID: 27452411).","journal-title":"Radiother Oncol"},{"issue":"4","key":"2198_CR40","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.1120\/jacmp.v11i4.3255.PMID:21081882;PMCID:PMC5720421","volume":"11","author":"WY Song","year":"2010","unstructured":"Song WY, Huh SN, Liang Y, White G, Nichols RC, Watkins WT, Mundt AJ, Mell LK. Dosimetric comparison study between intensity modulated radiation therapy and three-dimensional conformal proton therapy for pelvic bone marrow sparing in the treatment of cervical cancer. J Appl Clin Med Phys. 2010;11(4):3255. https:\/\/doi.org\/10.1120\/jacmp.v11i4.3255.PMID:21081882;PMCID:PMC5720421.","journal-title":"J Appl Clin Med Phys"},{"key":"2198_CR41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.radonc.2020.09.022","volume":"154","author":"EM Gort","year":"2021","unstructured":"Gort EM, Beukema JC, Matysiak W, Sijtsema NM, Aluwini S, Langendijk JA, Both S, Brouwer CL. Inter-fraction motion robustness and organ sparing potential of proton therapy for cervical cancer. Radiother Oncol. 2021;154:194\u2013200. https:\/\/doi.org\/10.1016\/j.radonc.2020.09.022. (PMID: 32956707).","journal-title":"Radiother Oncol"},{"issue":"2","key":"2198_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0360-3016(92)90052-j","volume":"22","author":"JD Slater","year":"1992","unstructured":"Slater JD, Slater JM, Wahlen S. The potential for proton beam therapy in locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1992;22(2):343\u20137. https:\/\/doi.org\/10.1016\/0360-3016(92)90052-j. (PMID: 1310969).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2198_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0360-3016(92)90054-l","volume":"22","author":"CV Levin","year":"1992","unstructured":"Levin CV. Potential for gain in the use of proton beam boost to the para-aortic lymph nodes in carcinoma of the cervix. Int J Radiat Oncol Biol Phys. 1992;22(2):355\u20139. https:\/\/doi.org\/10.1016\/0360-3016(92)90054-l. (PMID: 1310971).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2198_CR44","doi-asserted-by":"publisher","first-page":"e477","DOI":"10.1016\/j.ijrobp.2011.07.012","volume":"82","author":"AB Milby","year":"2012","unstructured":"Milby AB, Both S, Ingram M, Lin LL. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2012;82(3):e477\u201384. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.07.012. (PMID: 22177626).","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2198_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.radonc.2015.05.005","volume":"115","author":"E Dinges","year":"2015","unstructured":"Dinges E, Felderman N, McGuire S, Gross B, Bhatia S, Mott S, Buatti J, Wang D. Bone marrow sparing in intensity modulated proton therapy for cervical cancer: efficacy and robustness under range and setup uncertainties. Radiother Oncol. 2015;115(3):373\u20138. https:\/\/doi.org\/10.1016\/j.radonc.2015.05.005. (PMID: 25981130; PMCID: PMC4508248).","journal-title":"Radiother Oncol"},{"issue":"11","key":"2198_CR46","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00066-008-1872-9","volume":"184","author":"D Georg","year":"2008","unstructured":"Georg D, Georg P, Hillbrand M, P\u00f6tter R, Mock U. Assessment of improved organ at risk sparing for advanced cervix carcinoma utilizing precision radiotherapy techniques. Strahlenther Onkol. 2008;184(11):586\u201391. https:\/\/doi.org\/10.1007\/s00066-008-1872-9. (Epub 2008 Nov 19 PMID: 19016017).","journal-title":"Strahlenther Onkol"},{"issue":"20","key":"2198_CR47","doi-asserted-by":"publisher","first-page":"5179","DOI":"10.3390\/cancers13205179.PMID:34680328;PMCID:PMC8533850","volume":"13","author":"A Corbeau","year":"2021","unstructured":"Corbeau A, Nout RA, Mens JWM, Horeweg N, Godart J, Kerkhof EM, Kuipers SC, van Poelgeest MIE, Kroep JR, Boere IA, van Doorn HC, Hoogeman MS, van der Heide UA, Putter H, Welters MJP, van der Burg SH, Creutzberg CL, de Boer SM. PROTECT: prospective phase-II-trial evaluating adaptive proton therapy for cervical cancer to reduce the impact on morbidity and the immune system. Cancers (Basel). 2021;13(20):5179. https:\/\/doi.org\/10.3390\/cancers13205179.PMID:34680328;PMCID:PMC8533850.","journal-title":"Cancers (Basel)"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02198-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02198-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,12]],"date-time":"2023-01-12T04:04:52Z","timestamp":1673496292000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02198-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2198"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02198-4","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the local ethics committee (S-155\/2016) and by an independent expert group from the German Society for Radiooncology (DEGRO).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}